Matinas BioPharma
MTNB
MTNB
45 hedge funds and large institutions have $8.74M invested in Matinas BioPharma in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$344K | |
| 2 | +$64.7K | |
| 3 | +$23K | |
| 4 |
Citigroup
New York
|
+$18.5K |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.9K |
Top Sellers
| 1 | -$155K | |
| 2 | -$123K | |
| 3 | -$50K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$44.4K |
| 5 |
Goldman Sachs
New York
|
-$30.5K |